SYNTHOS RESEARCH

ConocoPhillips COP

Energy · Oil & Gas Exploration & Production · Synthos Deep Dive · 2026-08-04

$130.35
Watch

The Overview

ConocoPhillips finds and produces oil and natural gas. It is one of the largest independent producers in the world, and unlike most companies of its size it does almost nothing else — no refining, no petrol stations, no chemicals.

Financially it is in unusually good shape. It owes about $16 billion net, against annual cash earnings of roughly $24 billion — less than a year's worth. It carries no goodwill and no intangible assets at all, which means there is nothing on its balance sheet that can be written off in the way that regularly happens to pharmaceutical and technology companies. And its share price moves almost independently of the stock market: its beta of 0.122 is by far the lowest of the twelve companies in this group.

But we found a large error in the data, and it goes the wrong way.

The data file says ConocoPhillips spent $3.0 billion on capital projects last year and generated $16.8 billion of spare cash — which would be a free-cash-flow yield of nearly 11%, extraordinary for a company this size. The company's own annual report says it spent $12.6 billion. The data understates it by $9.5 billion, and the true spare cash was about $7.2 billion — a yield of 5.0%, roughly half.

That matters because the company paid out about $9.0 billion to shareholders last year in dividends and buybacks. On the true numbers, it paid out 125% of what it generated and funded the difference from its balance sheet. It can afford to do that for a while — its debt is very low — but not indefinitely, and not if oil prices fall.

On the other side, the oil-price environment looks genuinely favourable, and we can show that from sources that have nothing to do with ConocoPhillips. In this same batch of company filings, Deere notes "inflationary pressures, including those associated with rising oil prices" and that investors have "rotated... into commodity-linked sectors, particularly energy". Booking Holdings and Uber both blame higher air fares partly on "higher fuel costs associated with the conflict in the Middle East." Three unrelated companies describing the same thing is better evidence than any forecast.

The shares are $117.95. Analysts expect $9.61 per share this year — but the company earned only $1.89 in the first quarter, so nearly $7.72 has to come in the remaining nine months. That is a bet on oil prices, and the company reports again in two days.

Two other things worth knowing. The chief executive sold about $15 million of shares in March at $132.71 — 12.5% above today's price. And a board member sold her entire holding in June.

Our estimate of fair value is $135, about 15% higher; the average analyst says $141.


Putting a number on it: our fair-value estimate is $135 against a current price of $130.35 — real upside if our numbers are right.

Our summary metrics

Downside Risk (lower = safer)5/10Moderate

"Rated 5 — one of the cleanest balance sheets in this batch attached to an earnings stream that is entirely a commodity price, with a capital-return policy running above the cash it generates. Supports: funded net debt of $16,157M at 2025-12-31 against trailing EBITDA of $24,465M — 0.66x, the lowest leverage of any levered name here; interest coverage 9.42x; ZERO goodwill and ZERO intangible assets on a $121,939M balance sheet, which after the negative-tangible-equity readings on Pfizer, AT&T and Eaton in this batch is worth stating plainly; property, plant and equipment of $94,189M carried against $64,487M of equity; beta of 0.122, less than half the next-lowest name here and low enough to make this a genuine portfolio diversifier rather than a sector bet; and a twelve-month return of +27.2% against SPY's +24.3%, the only outperformer among the batch's cheaper names. Against that: on the CORRECTED capital-expenditure figure of $12,553M, fiscal-2025 free cash flow was $7,243M while the company returned approximately $9,040M — $5,018M of buybacks plus roughly $4,022M of dividends — which is 125% of free cash flow and was funded from the balance sheet; the entire earnings line is an unhedged commodity price, with the 2026 consensus of $9.608 requiring $7.72 across three remaining quarters after $1.89 in the first; revenue estimates rest on FIVE analysts against 10-12 on EPS; the chief executive sold 113,221 shares for approximately $15.0 million on 2026-03-31 at $132.71, 12.5% above today's price; a director sold her entire position in June; and the company reports in two days. Not a 4, because the capital return exceeds the cash generation and the price is a commodity. Not a 6, because there is no leverage, no goodwill and no refinancing question anywhere in this file."

Growth Quality4/10Moderate

"Rated 4 — a business whose revenue is a price times a volume, where the price is doing the work and the volume is invisible in every source available. Fiscal 2025 revenue was $58,714M, up 7.5% on $54,612M, with operating income of $11,495M at a 19.6% margin — but net income FELL from $9,218M to $7,988M and earnings per share from $7.82 to $6.36, an 18.7% decline, because the share count rose from 1,180.9M to 1,253.4M following the Marathon Oil transaction and depreciation rose from $9,645M to $11,681M. The March 2026 quarter went backwards: revenue $16,054M against $16,458M, down 2.5%; operating income $3,363M against $4,198M, down 19.9%; net income $2,183M against $2,849M, down 23.4%. Adjusted EPS of $1.89 nonetheless beat a $1.72 consensus by 9.9%, the fifth beat in six quarters. Consensus for 2026 is revenue of $69,017M — a 17.5% increase — and EPS of $9.608, against $1.89 delivered in the first quarter; that is a large oil-price assumption resting on FIVE analysts for the revenue line. `seg_prod` and `seg_geo` are both EMPTY, so no production, reserve or per-barrel figure appears anywhere in this dive. A 4: the price environment is improving and corroborated by three other issuers' filings in this batch, and nothing in the sources available lets us verify a single barrel."

Exponential Potential2/10Low

"Rated 2 — the lowest score we have assigned in this batch, and it is not a criticism. ConocoPhillips produces oil and natural gas. Its growth comes from drilling wells, acquiring acreage and commissioning long-dated liquefied-natural-gas and Alaskan projects, all of which are capital-intensive, decade-scale and inherently linear. There is no network effect, no operating-leverage cliff, no technology slope and no subscription layer. The one non-linear item anywhere in the file is the knowledge base's single claim — a named guest speaker at conviction 50 arguing that a potential change in Venezuela's status could make American energy companies' reparations claims collectible, with ConocoPhillips 'intended to capture a big chunk of that litigation claim.' That is an option on a legal outcome rather than on a business, it is unquantified, and nothing in the 10-K or 10-Q in this archive addresses it. The balance sheet itself is the honest statement of what this company is: $94,189M of property, plant and equipment, zero goodwill, zero intangibles, and 9,900 employees. A 2: a well-run extractor of a commodity, and the score is a description rather than a judgement."

Fair value$135 $85–$170
What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, We don’t publish a reverse-DCF cross-check for pre-profit companies — negative or missing earnings break that math — so take this number on our modeling alone.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

The Road Ahead

What we expect to matter in each window, and the evidence that would prove us wrong.

Short term 0-6 months

Neutral
Driver
"Two days from a print with an unusually demanding estimate attached. Consensus for 2026-08-06 is $2.90 of adjusted EPS on $18,786.7M of revenue against the $1.89 and $16,054M delivered in the March quarter — a 53.5% sequential earnings step and a 17.0% revenue step, and the largest implied sequential move in any estimate in this batch. That is an oil-price call rather than an operating forecast, and it is testable in 48 hours. The chart is constructive but not cheap: at $117.95 the stock sits 3.9% above a 50-day moving average of $113.50 and 9.2% above a 200-day of $108.04, 11.8% below the 52-week high of $133.80 and 37.7% above the low of $85.66, with RSI at 63.6 and MACD at +1.97. Twelve-month return is +27.2% against SPY's +24.3% — the only cheap name in this batch that has outperformed. But it fell 1.02% on the dive date against a market that rose, three-month relative performance is −5.6% against SPY's +7.6%, and the chief executive sold approximately $15.0 million of stock four months ago at $132.71."
What we’re watching
"The 2026-08-06 print against $2.90 of adjusted EPS and $18,786.7M of revenue, and specifically whether the revenue step is delivered — a 17% sequential increase in an exploration and production company is a realised-price outcome, not an operating one. Capital expenditure, which the 10-Q shows at $2,948M for the March quarter against $3,378M a year earlier; the corrected fiscal-2025 figure is $12,553M and the direction of that line determines free cash flow more than anything on the revenue side. The pace of the buyback: $5,018M in 2025 against $5,463M in 2024 and $5,400M in 2023, on corrected free cash flow of $7,243M — whether it is sustained tells you what management believes about the price deck. Any commentary on the litigation claim against Venezuela that our single knowledge-base claim identifies. And the general counsel transition: Kelly B. Rose retires as Senior Vice President, Legal and General Counsel effective 2026-09-01."
Confidence
Low

Medium term 6-24 months

Tailwind
Driver
"The medium-term case is a low-cost, low-leverage producer into an oil-price environment that three separate issuers in this batch independently describe as tightening. Deere's 10-Q for the April 2026 quarter records 'uncertainties related to ongoing geopolitical conflicts and inflationary pressures, including those associated with rising oil prices', and separately that 'investors rotated away from large-cap technology stocks into commodity-linked sectors, particularly energy.' Booking Holdings' 10-Q, filed on the date of this dive, attributes higher average flight ticket prices in part to 'higher fuel costs associated with the conflict in the Middle East.' Uber's 10-Q describes the same conflict raising flight prices and reducing capacity. None of those is ConocoPhillips talking about its own market — they are three unrelated companies describing the same input cost, and that is a materially better corroboration than a sell-side price deck. Against that backdrop the company's financial position is the strongest in this batch on the metrics that matter for a cyclical: funded net debt of $16,157M at 0.66x trailing EBITDA, zero goodwill, zero intangibles, and $6,981M of cash and short-term investments. Consensus EPS of $9.608 for 2026 and $8.706 for 2027 puts the stock at 12.3x and 13.6x."
What we’re watching
"Free cash flow against capital returns — the corrected numbers are the ones to watch and they are not comfortable. On the 10-K's capital expenditure of $12,553M, fiscal-2025 free cash flow was $7,243M against approximately $9,040M returned to shareholders, or 125%. That is sustainable for a period from a balance sheet carrying only 0.66 turns of net debt, and it is not a policy that survives a lower price deck. Whether capital expenditure stays near the $11.8B annualised run-rate the March quarter implies or rises with activity. Whether the dividend of $3.30 a share — costing roughly $4,022M — is raised, held or supplemented; on corrected free cash flow it is covered 1.80 times before buybacks and not at all after them. Whether the FIVE-analyst revenue estimates converge with the twelve-analyst EPS estimates, because at present the two rest on very different amounts of work. And whether the share count, which rose from 1,180.9M to 1,253.4M through the Marathon transaction and has since fallen to 1,218.9M, keeps shrinking."
Confidence
Medium

Long term 2+ years

Neutral
Driver
"Long term this is a commodity business and the honest position is that we have no differentiated view of the commodity. What can be said from the file is that ConocoPhillips is unusually well placed to survive whatever the price does: $94,189M of property, plant and equipment against $64,487M of equity and $16,157M of funded net debt; no goodwill and no intangible assets, so no impairment risk of the kind that sits on Pfizer's, AT&T's and Eaton's balance sheets in this same batch; 9,900 employees running a business with $58.7 billion of revenue; and a beta of 0.122 that says the market treats it as genuinely uncorrelated with everything else. The one long-dated, non-price item in the file is the knowledge base's single claim, from a named guest speaker at conviction 50, that a change in Venezuela's political status could make American energy companies' reparations claims collectible with ConocoPhillips capturing a large share — an option we cannot value and which appears nowhere in the filings."
What we’re watching
"Whether the oil-price environment three other issuers in this batch describe proves cyclical or structural. Whether capital discipline holds — the industry's history is that low leverage and high returns of capital at the top of a cycle become high leverage and suspended returns at the bottom, and ConocoPhillips is currently returning 125% of its free cash flow. Whether reserve replacement and production growth become visible; `seg_prod` and `seg_geo` are both empty and this dive contains no production figure at all, which is a genuine limitation on any long-run assessment. Succession: Ryan Lance has led the company since 2012, sold approximately $15.0 million of stock on 2026-03-31, and the general counsel retires on 2026-09-01. And the Venezuela claim, which is the only asymmetric item anyone has identified and which no filing in this archive mentions."
Confidence
Low

Exponential Potential

Exponential Potential2/10Low

"Rated 2 — the lowest score we have assigned in this batch, and it is not a criticism. ConocoPhillips produces oil and natural gas. Its growth comes from drilling wells, acquiring acreage and commissioning long-dated liquefied-natural-gas and Alaskan projects, all of which are capital-intensive, decade-scale and inherently linear. There is no network effect, no operating-leverage cliff, no technology slope and no subscription layer. The one non-linear item anywhere in the file is the knowledge base's single claim — a named guest speaker at conviction 50 arguing that a potential change in Venezuela's status could make American energy companies' reparations claims collectible, with ConocoPhillips 'intended to capture a big chunk of that litigation claim.' That is an option on a legal outcome rather than on a business, it is unquantified, and nothing in the 10-K or 10-Q in this archive addresses it. The balance sheet itself is the honest statement of what this company is: $94,189M of property, plant and equipment, zero goodwill, zero intangibles, and 9,900 employees. A 2: a well-run extractor of a commodity, and the score is a description rather than a judgement."

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.


> # ⚠ EARNINGS IN TWO DAYS — 2026-08-06

> ConocoPhillips reports second-quarter 2026 results on Thursday 2026-08-06. Consensus is $2.90 of adjusted EPS on $18,786.7 million of revenue.

> Read that against the March quarter it just delivered: $1.89 of adjusted EPS on $16,054 million. Consensus is asking for a 53.5% sequential earnings step and a 17.0% sequential revenue step — the largest implied sequential move in any estimate in this batch.

> That is an oil-price call, not an operating forecast, and it resolves in 48 hours.

> The verdict below is a Watch set with that timing and that estimate as explicit inputs.


Reference table

Street consensus$140.58 (+19.2%) · median $144.00 (+22.1%) · high $183 · low $111 (−5.9%) · 1 strong buy / 38 buy / 10 hold / 3 sell across 52 analysts
THE defect — capital expenditure understated by $9,530MVendor cf_a.capitalExpenditure for fiscal 2025: −$3,023M. The 10-K reports "Capital expenditures and investments (12,553)". The 10-Q corroborates the scale at $2,948M for the March 2026 quarter alone. Vendor freeCashFlow of $16,773M is overstated by $9,530M; the corrected figure is $7,243M
What that does to the headline metricVendor freeCashFlowYieldTTM 10.71% — the highest in this batch by four points. Corrected: 5.04%. capexToRevenueTTM reads 4.45% against an actual 21.4%
And what it does to the capital-return storyFiscal 2025: buybacks $5,018M plus dividends of roughly $4,022M = ~$9,040M returned against $7,243M of corrected free cash flow — 125%
Valuation20.0x trailing GAAP EPS ($5.89) · 12.28x 2026E · 13.55x 2027E · 12.63x 2028E · 6.55x trailing EBITDA on rebuilt EV · 19.8x corrected 2025 free cash flow
Balance sheet — the cleanest in this batchFunded net debt $16,157M at 0.66x trailing EBITDA · goodwill $0 · intangible assets $0 · property, plant and equipment $94,189M · equity $64,487M · interest coverage 9.42x · beta 0.122, less than half the next-lowest name here
The macro, corroborated from OUTSIDE this company's filingsDeere's 10-Q: "inflationary pressures, including those associated with rising oil prices"; "investors rotated away from large-cap technology stocks into commodity-linked sectors, particularly energy." Booking's 10-Q, filed today: "higher fuel costs associated with the conflict in the Middle East." Uber's 10-Q: the same conflict raising flight prices. Three unrelated issuers in this batch describing one environment
ConvictionVery lowONE knowledge-base claim across 51,928, from a named guest speaker at conviction 50, and it is about a Venezuelan litigation claim, not the business. Text and bare-ticker sweeps returned zero
Technicals−11.8% from the 52-week high of $133.80, +37.7% above the low of $85.66; +3.9% above the 50-DMA, +9.2% above the 200-DMA; RSI 63.6; MACD +1.97; 12-month +27.2% vs SPY +24.3%
InsidersChairman and chief executive Ryan Lance sold 113,221 shares at $132.7085 on 2026-03-31 — approximately $15.0 million, 12.5% above today's price. A director sold her ENTIRE position in June

What the experts actually said 1 traceable claims on COP · showing the highest-conviction voices

“With Venezuela potentially a US protectorate, American energy firms owed reparations gain renewed interest — ConocoPhillips intended to capture a big chunk of that litigation claim.”
Anthony Pompliano Showbullishconviction 502026-01-07anthony_pompliano-hsnv1Rcxs20:a04d1941c5

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

8296110125139Aug '25Nov '25Jan '26Apr '26Jun '26Aug '2652w hi $135Price 13050-DMA 117200-DMA 11252w lo $86

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Data summary: last close $130.35, 11% above the 50-day average ($117), 17% above the 200-day average ($112) — an uptrend. 3% below the 52-week high of $135, 52% above the 52-week low of $86.

Bollinger Bands 20-day average ± 2 standard deviations

7995111127143Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26Price 13020-day avg 126

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

Data summary: price $130.35 is currently inside the band (band $114–$138).

RSI (14) momentum gauge · 0–100

705030Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26RSI 61.3

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 61.

MACD 12 / 26 / 9 · trend & momentum

0Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26signal 4.1MACD 4.0

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Data summary: MACD is currently below its signal line by 0.13, negative momentum.

Relative performance vs S&P 500 & its sector (XLE (sector)), set to 100 a year ago

8399114130146Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26XLE (sector) 139COP 132S&P 500 119

Solid = COP · dashed = S&P 500 · dotted = XLE (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

021426384$58BFY23EPS $9$56BFY24EPS $8$61BFY25EPS $6$71BFY26EEPS $10$66BFY27EEPS $9$67BFY28EEPS $10$72BFY29EEPS $10$75BFY30EEPS $12

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$130.35
Market cap$159B
P/E trailing17×
P/E FY26E / FY27E13× / 14×
EV / Sales2.8×
EV / EBITDA6.4×
Gross margin50.8%
Net margin14.9%
Dividend yield2.58%
Beta0.123
52-wk range$86 – $135
RSI(14)65
50 / 200-DMA$117 / $112
12-mo return+33% (SPY +19%)
Street target$151 ($128–$189)
Analyst grades38 Buy · 10 Hold · 3 Sell
FMP ratingB+
Next earnings2026-08-06 — SECOND-QUARTER 2026 EARNINGS, TWO DAYS AFTER THIS DIVE. Vendor consensus adjusted EPS $2.90 on revenue of $18,786.7M — a 53.5% sequential EPS increase on the $1.89 just delivered and a 17.0% sequential revenue increase, which is the largest implied step in any estimate in this batch. The most recent filing-verified financials are as at 2026-03-31, from the 10-Q filed 2026-04-30.

1. The defect that changes the case

This is the first section rather than the eighth because it determines how the rest of the dive reads.

What the vendor reports (cf_a, fiscal 2025, US$M):

2025202420232022
Net cash provided by operating activities$19,796$20,124$19,965$28,314
capitalExpenditure($3,023)($12,118)($11,248)($10,159)
acquisitionsNet+$3,248($24)($2,724)($60)
freeCashFlow$16,773$8,006$8,717$18,155

What the 10-K filed 2026-02-17 reports:

> "Capital expenditures and investments | (12,553)"

And what the 10-Q filed 2026-04-30 reports for the March 2026 quarter:

> "Capital expenditures and investments | (2,948) | (3,378)" — with a segment breakdown across six operating segments summing to $2,948M.

> The vendor understates fiscal-2025 capital expenditure by $9,530 million — 76%. Corrected free cash flow for fiscal 2025 is $19,796M − $12,553M = $7,243 million, not $16,773 million.

Three independent confirmations that the filing is right and the payload is wrong. The 10-K states $12,553M directly. The March-quarter 10-Q shows $2,948M in a single quarter — an annualised run-rate near $11.8 billion. And the vendor's own prior years show $12,118M, $11,248M and $10,159M, so fiscal 2025 would be a 75% collapse in drilling spend by a company whose production did not collapse.

The consequences, listed because every one of them is a number a screen would use:

MetricVendorCorrected
Fiscal-2025 capital expenditure$3,023M$12,553M
Fiscal-2025 free cash flow$16,773M$7,243M
freeCashFlowYieldTTM10.71%~5.04%
capexToRevenueTTM4.45%21.4%
priceToFreeCashFlowRatioTTM~8.6x~19.8x
Fiscal-2025 capital returns as % of free cash flow~54%~125%

The last line is the one that matters. In fiscal 2025 ConocoPhillips repurchased $5,018 million of stock and paid roughly $4,022 million of dividends (1,218.9 million shares × the trailing $3.30). That is approximately $9,040 million returned against $7,243 million of corrected free cash flow — 125%.

We are not saying that is imprudent. With funded net debt of $16,157M at 0.66 times trailing EBITDA, ConocoPhillips can fund a shortfall of that size from the balance sheet for several years. We are saying that the published free-cash-flow yield of 10.71%, which is the single most attractive number anyone will see about this company, is more than double the true figure — and that on the true figure the shareholder return is being part-funded rather than fully earned.

2. The trading record, and what the March quarter actually showed

Annual (US$M except per share):

YearRevenueGrowthOperating incomeOp. marginNet incomeEPS (basic)Diluted sharesD&A
2020$18,765−59.6%−$1,830−$2,701−$2.511,078.0M$6,604
2021$46,056+145.4%$12,37426.9%$8,079$6.101,328.2M$7,252
2022 (peak)$78,582+70.6%$25,64132.6%$18,620$14.621,278.2M$7,844
2023$56,055−28.7%$15,03026.8%$10,922$9.081,205.7M$8,432
2024$54,612−2.6%$12,78323.4%$9,218$7.821,180.9M$9,645
2025$58,714+7.5%$11,49519.6%$7,988$6.361,253.4M$11,681

Read fiscal 2025 carefully, because the headline is misleading in the same direction as the cash-flow line. Revenue rose 7.5% and net income FELL 13.3%; earnings per share fell 18.7%, from $7.82 to $6.36. Three things did that: operating margin fell from 23.4% to 19.6%; depreciation and amortisation rose from $9,645M to $11,681M, up 21.1%; and the diluted share count rose from 1,180.9M to 1,253.4M, a 6.1% increase, following the Marathon Oil transaction. A company whose revenue grew, whose depreciation grew faster, and whose share count grew — the per-share outcome was a 19% decline.

Quarterly (US$M except per share):

QuarterRevenueYoYOperating incomeNet incomeGAAP EPSAdjusted EPSvs consensus
Q2 2024$13,588$3,459$2,322$1.99
Q3 2024$12,992$2,908$2,052$1.77
Q4 2024$14,238$2,979$2,300$1.90
Q1 2025$16,458$4,198$2,849$2.23$2.09vs $2.05 (+2.0%)
Q2 2025$13,979+2.9%$2,588$1,971$1.56$1.42vs $1.35 (+5.2%)
Q3 2025$14,969+15.2%$2,702$1,726$1.38$1.61vs $1.41 (+14.2%)
Q4 2025$13,308−6.5%$2,007$1,442$1.17$1.02vs $1.07 (−4.7%)
Q1 2026$16,054−2.5%$3,363$2,183$1.78$1.89vs $1.72 (+9.9%)

The March quarter went backwards year on year on every line: revenue −2.5%, operating income −19.9%, net income −23.4% — and still beat the adjusted consensus by 9.9%, because the consensus had been set lower still. Five beats in six quarters, one miss (the December 2025 quarter, −4.7%).

And the estimate for Thursday is the outlier in this entire batch: $2.90 of adjusted EPS on $18,786.7M of revenue, against $1.89 and $16,054M just delivered — a 53.5% sequential earnings step and a 17.0% revenue step. For an exploration and production company with essentially fixed short-run volumes, a 17% sequential revenue increase is a realised-price outcome. Consensus is making an oil-price call, and it resolves on 2026-08-06.

3. The macro, corroborated from outside the company

This is the one section in this dive where we can use evidence that is neither a sell-side forecast nor the company's own framing, and it is worth the space.

Three unrelated issuers in this same batch, in their own filings, describe the same environment:

> Deere & Company, 10-Q for the quarter ended 2026-05-03: "global equity markets were mixed, with most major market indices declining amid uncertainties related to ongoing geopolitical conflicts and inflationary pressures, including those associated with rising oil prices." And, separately: "market performance diverged as investors rotated away from large-cap technology stocks into commodity-linked sectors, particularly energy."

> Booking Holdings, 10-Q filed 2026-08-04: "Higher average flight ticket prices in the second quarter were driven in part by higher fuel costs associated with the conflict in the Middle East."

> Uber Technologies, 10-Q for the quarter ended 2026-03-31: "continued indirect impacts including elevated flight ticket prices, reduced flight capacity on certain routes, and a decrease in long-haul international travel demand, in each case related to impacts of the conflict in the Middle East."

A machinery manufacturer, an online travel agency and a ride-hailing company, filing independently, all describe higher oil prices arising from a Middle East conflict — and one of them explicitly records capital rotating into energy. That is a materially stronger corroboration of the price environment than any single forecast, and it is the principal reason the fair value below is not lower.

What it does NOT tell us is durability. A conflict-driven price is by construction reversible, and neither this dive nor any source in it contains a view on how long it lasts. The 2026 consensus of $9.608 per share embeds a price assumption we cannot independently verify; what we can verify is that the assumption is currently being made by three companies with no interest in making it.

4. Balance sheet — the cleanest in this batch

As at 2025-12-31 (the payload's most recent annual balance sheet; US$M):

2025-12-312024-12-312023-12-31
Cash and cash equivalents$6,497$5,607$5,635
Short-term investments$484$507$971
Cash and short-term investments$6,981$6,114$6,606
Property, plant and equipment, net$94,189$95,373$70,735
Goodwill$0$0$0
Intangible assets$0$0$0
Long-term investments$10,652$10,261$9,507
Total assets$121,939$122,780$95,924
Short-term debt$714$1,364$1,267
Long-term debt$22,424$22,641$17,025
Lease obligations (vendor field)$306$1,343$1,342
Total debt$23,444$25,348$19,634
Total stockholders' equity$64,487$64,796$49,279

> Funded net debt = $23,444M − $306M of leases − $6,981M of cash and short-term investments = $16,157M.

> Against trailing EBITDA of $24,465M, that is 0.66 times.

Three observations.

First, and it is worth stating plainly after this batch: there is no goodwill and there are no intangible assets. Pfizer carries $124,995M of goodwill and intangibles against $86,476M of equity; AT&T's tangible book value per share is negative $10.47; Eaton's tangible equity is roughly negative $12.5 billion; Booking's total equity is a $10.8 billion deficit. ConocoPhillips carries $94,189M of physical property against $64,487M of equity and nothing else. There is no impairment risk of that class here at all — which for a cyclical is a meaningful structural advantage, because the write-downs that hit this industry are on producing assets rather than on acquisition accounting.

Second, the vendor's netDebt is close to right for once. It reports the fiscal-2025 net debt as total debt less cash only, giving roughly $16,947M against our $16,463M including short-term investments and $16,157M funded. The omission of $484M of short-term investments is real but immaterial at this scale, and we record that as a rare near-miss rather than a defect. netDebtToEBITDATTM of 0.713x and evToEBITDATTM of 6.587x are both usable, which is unusual in this batch.

Third, the $10,652M of long-term investments is not netted anywhere and is 7.4% of the market capitalisation. The payload does not disaggregate it and neither do we.

Enterprise value rebuild: market capitalisation $143.695B plus total debt $23.444B less cash and short-term investments $6.981B = $160.158B, against the vendor's $161.145B — a 0.6% difference. We use $160.158B, giving EV/trailing EBITDA of 6.55x.

5. Valuation — priced in or room?

At $117.9475, market capitalisation $143.69B, rebuilt enterprise value $160.16B:

Trailing (TTM to 2026-03-31)2026E2027E2028E
Revenue$58,310M$69,016.8M (5 analysts)$64,911.0M (5)$66,709.0M (5)
Revenue growth+17.5% (vs 2025 actual)−5.9%+2.8%
Adjusted EPS$9.608 (10)$8.706 (12)$9.336 (7)
GAAP basic EPS$5.89
P/E20.0x (trailing GAAP)12.28x13.55x12.63x
EV / EBITDA ($24,465M trailing)6.55x
Net debt / EBITDA0.66x
Free cash flow yieldvendor 10.71% — REJECTED
Corrected 2025 free cash flow yield5.04%
Dividend yield2.80%

Estimate coverage is lopsided in a way worth naming: TEN, TWELVE and SEVEN analysts on 2026, 2027 and 2028 EPS, but only FIVE on revenue in each of those years. Twelve analysts are willing to forecast earnings per share and five are willing to forecast the revenue those earnings come from, which tells you the EPS estimates are price-deck outputs rather than independently modelled top lines. The 2029 and 2030 rows carry TWO analysts each on revenue and are excluded entirely.

Note also the shape. Consensus has 2026 revenue rising 17.5% and then FALLING 5.9% in 2027, with EPS at $9.608, $8.706 and $9.336. That is a price spike being modelled and then partially given back — which is a reasonable way to model a conflict premium, and it means the 2026 figure should not be extrapolated.

est.ebitdaAvg and est.ebitAvg show the fixed-ratio signature — NOT USED. From 2026 through 2030, ebitdaAvg is exactly 45.46% of revenueAvg and ebitAvg exactly 29.80% in every year. Independently, the 2025 ebitAvg of $18,193.5M against actual operating income of $11,495M is 58% too high. All forward valuation runs on epsAvg and revenueAvg.

Peer context. The vendor peer set is genuinely apposite: TotalEnergies ($189.7B), Petrobras ($120.6B), Enbridge ($116.6B), Canadian Natural Resources ($96.4B), Equinor ($93.7B), Enterprise Products ($82.5B), EOG Resources ($76.4B), Diamondback ($54.0B), BP ($18.6B). EOG and Diamondback are the closest structural comparables — independent US-focused exploration and production. No peer multiples are supplied in the file, so no peer-multiple comparison is drawn.

5a. What today's price assumes (the inversion)

At $117.9475 — 12.28x the 2026 consensus and 13.55x 2027 — the price embeds the following falsifiable claims, each with a number and a date:

5b. The return bridge (why the multiple moves)

Expected return over the next twelve months decomposes as: adjusted EPS growth (MINUS 9.4%, from 2026E $9.608 to 2027E $8.706) + multiple drift (EXPANSION, from 12.28x on the current forward year to roughly 15.5x, +26%) + dividend yield (+2.80%)+17%.

Our base of $135 therefore requires the multiple to expand, and on a falling earnings estimate, which is the fragile leg and is named as such. $135 is 15.5x the 2027 consensus against today's 13.55x.

The justification is that the current multiple is a trough-of-confidence multiple rather than a peak-of-earnings one. Consensus itself models 2026 as a spike year and 2027 as a partial give-back, so the 12.28x on 2026 is a peak-earnings multiple and the 13.55x on 2027 is closer to mid-cycle. A base at 15.5x on 2027 is asking the market to pay a normal large-cap producer multiple on a normalised year, on a company with 0.66 turns of leverage and no goodwill. That is not aggressive; it is also not free.

The honest alternative framing: at a FLAT 13.55x on the 2028 consensus of $9.336, the price is $126.50 — a 7.3% gain plus the 2.80% dividend. That is the no-re-rating case and it is the more conservative anchor. The bear at $85 is 9.8x the 2027 consensus and sits fractionally below the 52-week low of $85.66.

5c. Variant perception (where we differ, what would surprise)

Synthos fair values

All three anchors are multiples of the 2027 consensus adjusted EPS distribution (mean $8.706, low $6.887, high $9.668, 12 analysts) — chosen over 2026 because it carries more EPS coverage and because consensus models 2026 as a price spike.

Base is 14.5% above spot; asymmetry approximately 1.58:1 to the upside (27.9% down, 44.1% up). On a normal name that ratio would support a Tactical position. What stops it here is that the single most attractive published metric is a vendor error we have had to correct downward by more than half, that the capital return exceeded the corrected cash generation by 25%, that the chief executive sold $15.0 million of stock four months ago, and that the print is in two days on an estimate requiring a 53.5% sequential step.

6. Knowledge base — one claim, and it is about a lawsuit

Raw hits: 1. Entity matches: 1. Text matches: 0. Case-sensitive bare-ticker matches: 0. Used as name-level conviction on the business: 0. Discarded for collision: 81 (a deliberately broad sweep, discarded in full).

The single claim, verbatim:

> 2026-01-07 · bullish · conviction 50 · channel: anthony_pompliano_show · SPEAKER: Jeff Park

> "With Venezuela potentially a US protectorate, American energy firms owed reparations gain renewed interest — ConocoPhillips intended to capture a big chunk of that litigation claim."

A named guest speaker, name-level, and about a legal claim rather than about production, reserves, cost position, capital allocation or price. Per the house rule on this channel, the host's own voice is low-weighted and guests are first-class; Jeff Park is a guest and the claim is treated at its stated conviction of 50, which is modest. Nothing in the 10-K or either 10-Q in this archive mentions a Venezuelan reparations claim, so the claim is unverified from the sources available and is recorded as an unquantified option rather than used in the valuation. It is referenced once in the bull case, labelled.

The sweeps that returned nothing, reported so the method is auditable. A supplementary text sweep on conocophillips, permian basin and us shale production returned zero additional claims. A case-sensitive word-boundary sweep on the bare ticker COP returned ZERO — which is worth stating explicitly, because a three-letter uppercase string that also denotes climate conferences and law enforcement was the expected collision risk on this name and it did not materialise. A deliberately broad sweep on the generic terms shale, permian and us oil production returned 81 matches, NOT ONE of which names ConocoPhillips; that sweep is discarded in full as sector-level noise rather than mined for atmosphere.

Conclusion, stated as a finding. The Synthos knowledge base has no view on ConocoPhillips as a business. It has one modest-conviction observation about a litigation claim. Conviction rating: Very low. Breadth: 1. Net conviction: none. No concentration sensitivity test is possible. The emptiness is an explicit input to the Watch verdict: on a name where the price depends on a commodity, the sell side is split three ways and our own research library is silent, there is no basis for a differentiated position.

7. Data integrity — what we rejected from the vendor file and why

Eight findings. One of them — the first — is the largest single-line error found anywhere in this batch.

1. capitalExpenditure for fiscal 2025 understates the filed figure by $9,530M (76%) — REJECTED, and every derived metric rebuilt. The vendor reports −$3,023M; the 10-K filed 2026-02-17 reports "Capital expenditures and investments | (12,553)"; the 10-Q filed 2026-04-30 reports $2,948M for the March 2026 quarter alone, with a six-segment breakdown that sums to it. The vendor's own prior years ($12,118M, $11,248M, $10,159M) make a $3.0 billion year implausible on its face. Consequentially rejected and rebuilt: freeCashFlow (from $16,773M to $7,243M), freeCashFlowYieldTTM (from 10.71% to approximately 5.04%), capexToRevenueTTM (from 4.45% to approximately 21.4%), priceToFreeCashFlowRatioTTM and evToFreeCashFlowTTM. Note also that acquisitionsNet for the same year reads a POSITIVE $3,248M, which suggests the investing section has been mis-split rather than a single line dropped.

2. seg_prod and seg_geo are BOTH EMPTY. ConocoPhillips reports six operating segments — the 10-Q's capital-expenditure table alone shows them — and reports production volumes, realised prices and reserves. None of it is in the payload, and no production, reserve, price-per-barrel or per-unit-cost figure appears anywhere in this dive as a result. On an exploration and production company that is a material limitation and it is stated rather than worked around.

3. est.ebitdaAvg and est.ebitAvg show the fixed-ratio signature — NOT USED. From 2026 through 2030, ebitdaAvg is exactly 45.46% of revenueAvg and ebitAvg exactly 29.80% in every year. Independently, the 2025 ebitAvg of $18,193.5M is 58% above actual operating income of $11,495M. All forward valuation runs on epsAvg and revenueAvg.

4. Revenue and EPS estimates rest on very different amounts of analyst work — flagged rather than corrected. FIVE analysts on revenue for each of 2026, 2027 and 2028, against TEN, TWELVE and SEVEN on EPS. Twelve analysts will forecast earnings and five will forecast the revenue producing them, which means the EPS estimates are price-deck outputs. The 2029 and 2030 revenue rows carry TWO analysts and are excluded entirely.

5. epsdiluted is NULL on every row and eps is the basic figure. The vendor's fiscal-2025 eps of 6.36 is basic on 1,253.4M shares; the earnings-calendar actuals ($2.09, $1.42, $1.61, $1.02, $1.89) are the company's adjusted figures and differ from GAAP in every quarter — for the March 2026 quarter, GAAP $1.78 against adjusted $1.89. All EPS figures here are labelled by basis.

6. netDebt omits $484M of short-term investments — a rare near-miss, recorded for completeness. The vendor's fiscal-2025 net debt of roughly $16,947M is total debt less cash only. Corrected including short-term investments it is $16,463M, and excluding $306M of lease obligations, $16,157M funded. At this scale the difference is immaterial and, unusually for this batch, netDebtToEBITDATTM (0.713x) and evToEBITDATTM (6.587x) are both usable as published.

7. dividendPerShareTTM of $3.30 is the trailing total and no filing in this archive states the declared quarterly rate. profile.lastDiv is null. The trailing figure is used throughout and labelled as trailing; no forward run-rate is asserted. dividendPayoutRatioTTM of 55.0% is arithmetically correct on trailing GAAP EPS of $5.89.

8. quote.yearHigh/yearLow ($135.87 / $85.57) disagree with tech.hi52/lo52 ($133.80 / $85.66) — we use tech. The discrepancies are 1.5% and 0.1%. Note also that tech.max_dd_from_peak of −12.6% is only marginally deeper than pct_from_hi of −11.8%, meaning the six-year peak sits close to the 52-week high — ConocoPhillips is one of the few names in this batch trading near its multi-year peak rather than well below it.

Not defects, correctly reported and worth recording: the share count reconciles exactly (the 8-K of 2026-05-14 states 1,218,853,041 shares outstanding and entitled to vote at the annual-meeting record date, against 1,218.3M implied by market capitalisation — a 0.04% difference); goodwill and intangibleAssets are both zero and both are correct, which is a genuine structural feature rather than a missing field; interestCoverageRatioTTM of 9.42x is consistent; effectiveTaxRateTTM of 36.6% is consistent with an international producer's tax profile; priceToBookRatioTTM of 2.24x is meaningful here because the equity is real; and the vendor's composite rating of B+ / 3 with a discounted-cash-flow sub-score of 5 is not rejected — though we note that a cash-flow-based sub-score computed on a free-cash-flow figure overstated by $9.5 billion should be treated with the same suspicion as the underlying number.

Non-equity tripwire — checked and passed, and the low beta made the check necessary. COP is common stock, NYSE-listed, beta 0.122 — by far the lowest in this batch and low enough to warrant scrutiny — but the security is confirmed as common equity by a variable dividend (the trailing $3.30 is not a fixed coupon), a 52-week range of $85.66 to $133.80 (a 56.2% range, the second-widest here), volume of 4.96 million shares (roughly $585M of turnover), and 1,218,853,041 shares outstanding per the annual-meeting 8-K. A 0.122 beta on a stock with a 56% annual range is a genuinely uncorrelated equity, not a fixed-income-like instrument — the volatility is high and simply does not coincide with the market's.

8. Technicals

Today's move

COP closed 2026-08-04 at $117.9475, DOWN $1.2125 or 1.02% from $119.16 — one of only two declines in this batch on a day when most of these names rose. It opened at $117.64, traded $116.08 to $118.465, and closed mid-range on 4,956,545 shares — roughly $585 million of turnover, the lightest in this batch. No company-specific news appears in this file dated 2026-08-04; the last company event was the 8-K of 2026-06-23 recording the general counsel's retirement. A 1% decline on light volume two days before a print that requires a 53.5% sequential earnings step is not an encouraging tape reading, and it is recorded as such.

9. Insiders — the most negative table in this batch

Eight transactions:

PersonRoleTypeSharesPriceDateHolding after
Ryan M. LanceChairman and CEOS-SALE113,221$132.70852026-03-31350,000 (indirect)
Sharmila MulliganDirectorS-SALE1,974$119.002026-06-10ZERO
Nicholas G. OldsExecutive Vice PresidentG-Gift (disposition)1,903$02026-03-313,492
Robert A. NiblockDirectorA-Award (stock units)322$02026-06-1595,532
Timothy A. LeachDirectorM-Exempt ×2 (units to stock)2,230$02026-04-15413,441
William H. McRavenDirectorM-Exempt ×2 (units to stock)2,230$02026-04-1523,537

The reading, and it is the least encouraging insider table in this batch.

The chief executive sold 113,221 shares at $132.7085 on 2026-03-31 — approximately $15.03 million — at a price 12.5% ABOVE today's close. The disposition was from an indirect holding, leaving 350,000 shares. A fifteen-million-dollar sale by a chairman and chief executive four months before a quarterly report is the single largest insider disposal in this batch by value, and while it may well be scheduled diversification, the file contains no Rule 10b5-1 designation and we do not assume one.

A director sold her entire remaining position. Sharmila Mulligan sold 1,974 shares at $119.00 on 2026-06-10 and the record shows securitiesOwned: 0 afterwards. The amount is trivial — approximately $235,000 — but going to zero is qualitatively different from trimming, and it happened at a price within 1% of today's.

Everything else is routine: two directors converting stock units to common stock on the same date, one annual award, and an executive vice president's gift.

What the file does NOT contain is a single open-market purchase. Net: mildly to moderately negative, and it is one of the four reasons this dive concludes Watch rather than Buy.

10. Verdict, kill-criteria and flip conditions

Watch.

What is genuinely good, and none of it is in dispute: an enterprise value of $160.2 billion on trailing EBITDA of $24.5 billion — 6.55 times; funded net debt of $16.2 billion at 0.66 turns, the lowest leverage of any levered company in this batch; zero goodwill and zero intangible assets on a $121.9 billion balance sheet, against negative tangible equity at Pfizer, AT&T, Eaton and Booking in this same batch; interest coverage of 9.42x; a beta of 0.122, less than half the next-lowest name here, making this a genuine portfolio diversifier; a twelve-month return of +27.2% against SPY's +24.3%, the only cheap name in this batch to have outperformed; five adjusted-EPS beats in six quarters; and an oil-price environment corroborated not by a forecast but by three unrelated issuers in this batch describing it in their own filings.

What stops us: the single most attractive published metric about this company is wrong. The vendor's 10.71% free-cash-flow yield rests on a fiscal-2025 capital-expenditure figure of $3,023 million against the 10-K's $12,553 million; corrected, it is 5.04%, and on that basis the company returned approximately 125% of its free cash flow to shareholders in 2025. The 2026 consensus of $9.608 requires $7.72 across three remaining quarters after $1.89 in the first, and the revenue estimate underpinning it rests on FIVE analysts. seg_prod and seg_geo are both empty, so this dive contains no production, reserve or realised-price figure at all. The chief executive sold approximately $15.0 million of stock on 2026-03-31 at $132.71 and a director sold her entire holding in June. Our knowledge base has one claim and it is about a lawsuit. And the company reports in two days on the most demanding sequential estimate in this batch.

The distinction that matters. This is not a judgement that ConocoPhillips is a poor business or that oil prices are about to fall. It is the observation that the correction we were obliged to make removes more than half of the headline cash-flow attraction, and everything left — a 6.55x EBITDA multiple, a clean balance sheet, a corroborated price environment — is good but not exceptional at a 14.5% base-case return. Add a chief executive selling $15 million, a director exiting entirely, an empty research lane, no production data of any kind, and a print in 48 hours on a 53.5% sequential step, and the correct answer is to watch Thursday and decide afterwards. The information that would resolve this arrives in two days, and there is no reason to pre-empt it.

Pre-registered KILL criteria — what would take this to Avoid:

Pre-registered FLIP conditions — what would take this to Buy — Tactical:

Where COP fits in the Synthos Framework Portfolio. The energy / real-asset sleeve, at 0% today with a 2-3% target on a confirmatory print on 2026-08-06 or a fill near $100. On batch overlap, and it is the strongest portfolio argument in this dive: ConocoPhillips has a beta of 0.122 against a batch in which the next lowest is Pfizer at 0.28 and the highest is Shopify at 2.59. It is the only position here whose return does not depend on the equity market, on a capital-expenditure cycle, or on a technology outcome — and Deere's own 10-Q records capital rotating "into commodity-linked sectors, particularly energy", which is the mechanism by which that diversification pays. That is a real portfolio-construction case and it survives the free-cash-flow correction; what does not survive it is the case for owning this name on valuation alone. Logged as a tracked Synthos call (Watch) as of 2026-08-04 at $117.9475.

Single biggest risk: the oil price, compounded by a payout larger than the cash coming in. ConocoPhillips has no meaningful business other than realised commodity prices times volumes, and on corrected numbers it returned approximately $9.04 billion to shareholders in 2025 against $7.24 billion of free cash flow — 125%. At 0.66 turns of net debt that is comfortably affordable for several years, and it is not a policy that survives a materially lower price deck. The 2026 consensus of $9.608 a share embeds a price assumption that three unrelated issuers in this batch independently corroborate and that none of them expects to explain — a conflict premium is by construction reversible. The first hard evidence arrives on 2026-08-06, and consensus is asking that quarter for a 53.5% sequential increase in earnings and a 17.0% increase in revenue. There is no reason to take the position before that number prints.


Provenance & disclosures